Clinical trials
Phase 1/2 Lymphoma trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
| Completed | 4 |
| Terminated | 3 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cyclacel Pharmaceuticals, Inc. | 2 |
| Pfizer | 2 |
| Asan Medical Center | 1 |
| AstraZeneca | 1 |
| Dren Bio | 1 |
| Eutilex | 1 |
| Hoffmann-La Roche | 1 |
| IGM Biosciences, Inc. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 15 |
| Lymphoma, Non-Hodgkin | 4 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Hodgkin Disease | 2 |
| Leukemia | 2 |
| Leukemia, Large Granular Lymphocytic | 2 |
| Lymphoma, B-Cell | 2 |
| Lymphoma, B-Cell, Marginal Zone | 2 |
| Lymphoma, Extranodal NK-T-Cell | 2 |
| Lymphoma, Follicular | 2 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.